Interchangeability and Pharmacy-Level Substitution
Upon completion of the activity, participants should be able to:
1. Summarize key aspects of current and proposed regulations regarding interchangeability and pharmacist-level substitution with biosimilars
2. Access information on approved biosimilars to determine if pharmacy-level substitution will be applicable
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.